DB1 EVALUATING THE COST-EFFECTIVENESS OF THERAPY CONVERSION FROM BASAL INSULIN TO BIPHASIC INSULIN ASPART 30/70 IN PATIENTS WITH TYPE 2 DIABETES IN CHINA- A MODELING STUDY OF LONG-TERM COSTS AND HEALTH OUTCOMES
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)73078-9
https://www.valueinhealthjournal.com/article/S1098-3015(11)73078-9/fulltext
Title :
DB1 EVALUATING THE COST-EFFECTIVENESS OF THERAPY CONVERSION FROM BASAL INSULIN TO BIPHASIC INSULIN ASPART 30/70 IN PATIENTS WITH TYPE 2 DIABETES IN CHINA- A MODELING STUDY OF LONG-TERM COSTS AND HEALTH OUTCOMES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73078-9&doi=10.1016/S1098-3015(11)73078-9
First page :
A507
Section Title :
RESEARCH PODIUM ABSTRACTS
Open access? :
No
Section Order :
1238